Clinical Trial Update: Iodine-131 Anti-B1 Antibody (Tositumomab and Iodine I 131 Tositumomab) for Previously Untreated, Advanced-stage, Low Grade Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

This report describes a Phase 2 trial of the radioimmunotherapy combination Tositumomab with Iodine-131 for previously untreated, advanced-stage, low-grade Non-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Indolent Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Iodine-131 (Iodine-131)
• Tositumomab (tositumomab)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Lymphoma, Non-Hodgkin | Phase 2 | Status: COMPLETED | Results posted: 2012-07-04